67例肝门部胆管癌的治疗体会  

Experience in the treatment of hilar cholangiocarcinoma in 76 cases

作　　者：张建龙[1] 肖治宇[1] 唐启斌[1] 叶华[1] 王捷[1] 

机构地区：[1]中山大学附属孙逸仙纪念医院肝胆外科,广州510120

出　　处：《岭南现代临床外科》2008年第5期377-378,381,共3页Lingnan Modern Clinics in Surgery

摘　　要：目的探讨肝门部胆管癌的治疗方法。方法回顾性分析我科2004年1月～2007年12月行手术治疗的67例肝门部胆管癌的临床资料。结果手术切除32例,手术切除率为47.7%。1,3年生存率分别为78.6%,17%。各类引流组35例,1年生存率为55.3%、3年生存率为0,手术切除组疗效优于姑息引流组(P<0.05)。结论手术切除是目前治疗肝门部胆管癌最有效的方法。对于不可切除的肝门部胆管癌患者,充分合理的内外引流可以改善其生活质量。Objective To investigate the therapeutic methods of hilar eholangiocarcinoma. Methods 67 cases with hilar cholangiocarcinoma were analyzed retrospectively. Results Among the 67 cases. 32 cases underwent surgical resection and the resection rate was 47.7%. In the surgical resection group, the l and-3year survival rate were 78.6% and 17% respectively. 35 cases underwent various drainage and 1 and 3-year survival rate were 55.3% and zero. In the therapeutic efficacy, the surgical resection group was significantly better than that simple drainage group（P〈0.05）. Conclusion Surgical resection is most effective method for the treatment of hilar cholangio carcinoma at present. In the cases of unresectable hilar cholangiocarcinoma, a sufficient, reasonable use of internal and external drainag would improve the patient＇s quality of life.

关 键 词：肝门部胆管癌 外科手术 

分 类 号：R735.8[医药卫生—肿瘤]